Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Rhabdomyosarcoma × Idarubicin × Sarcoma × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Sarcoma, Synovial 1 Sarcoma, Myeloid 1 Sarcoma 1 Rhabdomyosarcoma 1 Myeloproliferative Disorders 1 Leukemia, Myeloid, Acute 1 Blast Crisis 1

Interventions

Cyclophosphamide 23 Vincristine 21 Irinotecan 20 Temozolomide 17 Doxorubicin 14 Radiotherapy 13 Filgrastim 13 Ifosfamide 12 Dactinomycin 12 Etoposide 10 Granulocyte Colony-Stimulating Factor 9 Melphalan 8 Magnetic Resonance Spectroscopy 8 pegfilgrastim 7 Vinorelbine 7 Sirolimus 7 Radiation 7 X-Rays 6 Topotecan 6 Specimen Handling 6 fludarabine 5 cixutumumab 5 Phantoms, Imaging 5 Gemcitabine 5 Busulfan 5 temsirolimus 4 fludarabine phosphate 4 etoposide phosphate 4 Thiotepa 4 Peripheral Blood Stem Cell Transplantation 4

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT00876031 2022-11-08

CWS-2007-HR

University Hospital Tuebingen

Phase 3 Completed

Rhabdomyosarcoma, Sarcoma, Sarcoma, Synovial

Data powered by HemOnc (CC BY 4.0) Colophon ⚡